Skandinaviska Enskilda Banken (SEB)’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,725
Closed -$306K 970
2023
Q2
$306K Buy
3,725
+1,386
+59% +$114K ﹤0.01% 831
2023
Q1
$240K Sell
2,339
-114
-5% -$11.7K ﹤0.01% 815
2022
Q4
$359K Buy
+2,453
New +$359K ﹤0.01% 756
2021
Q3
Sell
-1,212
Closed -$412K 1066
2021
Q2
$412K Buy
+1,212
New +$412K ﹤0.01% 904